Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GoodRx Holdings, Inc.GDRX · Entity 4838 | President, Consumer | April 01, 2022 | April 06, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GoodRx Holdings, Inc.
Report date April 01, 2022 · Filed April 06, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 3,007,708 |
Ending reported balance
After 2022-04-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-04-01 · Exercise / conversion · Acquired 62,500 · Balance 3,038,696 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Row 2 · 2022-04-01 · Tax withholding · Disposed 30,988 · Balance 3,007,708 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 625,000 |
Reported balance
After 2022-04-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-04-01 · Exercise / conversion · Disposed 62,500 · Balance 625,000 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3: On October 30, 2020, the reporting person was granted 1,000,000 restricted stock units, vesting in 16 equal quarterly installments commencing on October 1, 2020, subject to the reporting person's continued employment through each applicable vesting date. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Trust | 197,418 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 197,418 F2: Shares held by The Arisa Slutsky Spousal Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2: Shares held by The Arisa Slutsky Spousal Trust.
F3: On October 30, 2020, the reporting person was granted 1,000,000 restricted stock units, vesting in 16 equal quarterly installments commencing on October 1, 2020, subject to the reporting person's continued employment through each applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2022 Filed Apr 6, 2022 00:37 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Units · Derivative | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-013921 · doc4.xml · derivative · entry 4 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 625,000 Underlying: Class A Common Stock · 62,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: On October 30, 2020, the reporting person was granted 1,000,000 restricted stock units, vesting in 16 equal quarterly installments commencing on October 1, 2020, subject to the reporting person's continued employment through each applicable vesting date. F3 · derivative.expiration_date: On October 30, 2020, the reporting person was granted 1,000,000 restricted stock units, vesting in 16 equal quarterly installments commencing on October 1, 2020, subject to the reporting person's continued employment through each applicable vesting date. Read SEC document |
| April 01, 2022 Filed Apr 6, 2022 00:37 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 30,988 | $19.33 | $598,998.04 |
DisclosureSEC source: 0000899243-22-013921 · doc4.xml · nonDerivative · entry 2 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,007,708 Read SEC document |
| April 01, 2022 Filed Apr 6, 2022 00:37 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 62,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-013921 · doc4.xml · nonDerivative · entry 1 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,038,696 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 18, 2022 Filed Mar 22, 2022 22:51 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionStock Option (Right to Buy) · Derivative | 91,667 | $0.00 Strike: $2.18 | $0.00 |
DisclosureSEC source: 0000899243-22-011841 · doc4.xml · derivative · entry 3 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 91,667 shares Expires 2027-11-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| March 18, 2022 Filed Mar 22, 2022 22:51 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 91,667 | $2.18 | $199,907.39 |
DisclosureSEC source: 0000899243-22-011841 · doc4.xml · nonDerivative · entry 1 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,976,196 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 02:28 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 14,204 | $32.85 | $466,626.97 |
DisclosureSEC source: 0000899243-22-000702 · doc4.xml · nonDerivative · entry 4 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,884,529 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted September 1, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.64 to $33.14, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 02:28 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 21,625 | $32.10 | $694,168.99 |
DisclosureSEC source: 0000899243-22-000702 · doc4.xml · nonDerivative · entry 3 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,898,733 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted September 1, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.63 to $32.62, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 01, 2022 Filed Jan 5, 2022 02:28 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Units · Derivative | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-000702 · doc4.xml · derivative · entry 6 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 687,500 Underlying: Class A Common Stock · 62,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F6 · derivative.exercise_date: On October 30, 2020, the reporting person was granted 1,000,000 restricted stock units, vesting in 16 equal quarterly installments commencing on October 1, 2020, subject to the reporting person's continued employment through each applicable vesting date. F6 · derivative.expiration_date: On October 30, 2020, the reporting person was granted 1,000,000 restricted stock units, vesting in 16 equal quarterly installments commencing on October 1, 2020, subject to the reporting person's continued employment through each applicable vesting date. Read SEC document |
| January 01, 2022 Filed Jan 5, 2022 02:28 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 26,671 | $32.68 | $871,608.28 |
DisclosureSEC source: 0000899243-22-000702 · doc4.xml · nonDerivative · entry 2 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,920,358 Read SEC document |
| January 01, 2022 Filed Jan 5, 2022 02:28 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 62,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-000702 · doc4.xml · nonDerivative · entry 1 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,947,029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 21:08 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 126,297 | $41.28 | $5,213,136.01 |
DisclosureSEC source: 0000899243-21-047755 · doc4.xml · nonDerivative · entry 3 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,884,529 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted November 17, 2020, as amended September 1, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.76 to $41.71, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 21:08 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 26,631 | $40.31 | $1,073,389.09 |
DisclosureSEC source: 0000899243-21-047755 · doc4.xml · nonDerivative · entry 2 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,010,826 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted November 17, 2020, as amended September 1, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.76 to $40.73, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 21:08 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 12,072 | $39.28 | $474,160.39 |
DisclosureSEC source: 0000899243-21-047755 · doc4.xml · nonDerivative · entry 1 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,037,457 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted November 17, 2020, as amended September 1, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.76 to $39.75, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 22, 2021 Filed Oct 27, 2021 00:11 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 15,950 | $46.93 | $748,587.73 |
DisclosureSEC source: 0000899243-21-041627 · doc4.xml · nonDerivative · entry 2 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,049,529 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted November 17, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.50 to $47.24, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 22, 2021 Filed Oct 27, 2021 00:11 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 4,050 | $45.98 | $186,208.88 |
DisclosureSEC source: 0000899243-21-041627 · doc4.xml · nonDerivative · entry 1 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,065,479 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted November 17, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.50 to $46.49, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 00:19 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Units · Derivative | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-038932 · doc4.xml · derivative · entry 8 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750,000 Underlying: Class A Common Stock · 62,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F8 · derivative.exercise_date: On October 30, 2020, the reporting person was granted 1,000,000 restricted stock units, vesting in 16 equal quarterly installments commencing on October 1, 2020, subject to the reporting person's continued employment through each applicable vesting date. F8 · derivative.expiration_date: On October 30, 2020, the reporting person was granted 1,000,000 restricted stock units, vesting in 16 equal quarterly installments commencing on October 1, 2020, subject to the reporting person's continued employment through each applicable vesting date. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 00:19 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 4,894 | $44.22 | $216,392.61 |
DisclosureSEC source: 0000899243-21-038932 · doc4.xml · nonDerivative · entry 6 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,069,529 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted September 1, 2021. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.11 to $44.40, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 00:19 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 12,555 | $43.67 | $548,330.84 |
DisclosureSEC source: 0000899243-21-038932 · doc4.xml · nonDerivative · entry 5 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,074,423 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted September 1, 2021. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.11 to $44.04, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 00:19 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 13,669 | $42.45 | $580,201.21 |
DisclosureSEC source: 0000899243-21-038932 · doc4.xml · nonDerivative · entry 4 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,086,978 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted September 1, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.11 to $43.09, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 00:19 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 3,900 | $41.55 | $162,039.93 |
DisclosureSEC source: 0000899243-21-038932 · doc4.xml · nonDerivative · entry 3 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,100,647 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted September 1, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.08 to $42.05, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 00:19 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 30,988 | $41.02 | $1,271,127.76 |
DisclosureSEC source: 0000899243-21-038932 · doc4.xml · nonDerivative · entry 2 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,104,547 Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 00:19 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 62,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-038932 · doc4.xml · nonDerivative · entry 1 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,135,535 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| September 22, 2021 Filed Sep 23, 2021 14:45 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 200 | $47.05 | $9,410.00 |
DisclosureSEC source: 0000899243-21-037261 · doc4.xml · nonDerivative · entry 3 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,073,035 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted November 17, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.04 to $47.06, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 22, 2021 Filed Sep 23, 2021 14:45 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 6,200 | $46.22 | $286,555.94 |
DisclosureSEC source: 0000899243-21-037261 · doc4.xml · nonDerivative · entry 2 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,073,235 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted November 17, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.93 to $46.70, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 22, 2021 Filed Sep 23, 2021 14:45 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 13,600 | $45.52 | $619,089.68 |
DisclosureSEC source: 0000899243-21-037261 · doc4.xml · nonDerivative · entry 1 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,079,435 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted November 17, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.93 to $45.92, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 23:56 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 25,000 | $45.00 | $1,125,025.00 |
DisclosureSEC source: 0000899243-21-036348 · doc4.xml · nonDerivative · entry 1 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 197,418 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted November 17, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.01, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: Shares held by The Arisa Slutsky Spousal Trust. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 20:10 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 20,000 | $33.33 | $666,622.00 |
DisclosureSEC source: 0000899243-21-034142 · doc4.xml · nonDerivative · entry 1 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,093,035 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted November 17, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.05 to $33.68, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 12, 2021 Filed Aug 16, 2021 23:53 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 5,900 | $33.00 | $194,700.00 |
DisclosureSEC source: 0000899243-21-033163 · doc4.xml · nonDerivative · entry 1 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,113,035 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted November 17, 2020. Read SEC document |
| July 30, 2021 Filed Aug 3, 2021 21:21 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 800 | $33.01 | $26,406.96 |
DisclosureSEC source: 0000899243-21-031309 · doc4.xml · nonDerivative · entry 1 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,118,935 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted November 17, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.015, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 29, 2021 Filed Jul 30, 2021 22:03 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 5,900 | $33.02 | $194,825.67 |
DisclosureSEC source: 0000899243-21-030853 · doc4.xml · nonDerivative · entry 2 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,119,735 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted November 17, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.14, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 28, 2021 Filed Jul 30, 2021 22:03 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 7,400 | $33.00 | $244,234.78 |
DisclosureSEC source: 0000899243-21-030853 · doc4.xml · nonDerivative · entry 1 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,125,635 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted November 17, 2020. F2 · price: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted November 17, 2020. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 21:59 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Units · Derivative | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-027309 · doc4.xml · derivative · entry 3 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 812,500 Underlying: Class A Common Stock · 62,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: On October 30, 2020, the reporting person was granted 1,000,000 restricted stock units, vesting in 16 equal quarterly installments commencing on October 1, 2020, subject to the reporting person's continued employment through each applicable vesting date. F2 · derivative.expiration_date: On October 30, 2020, the reporting person was granted 1,000,000 restricted stock units, vesting in 16 equal quarterly installments commencing on October 1, 2020, subject to the reporting person's continued employment through each applicable vesting date. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 21:59 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 30,988 | $36.01 | $1,115,877.88 |
DisclosureSEC source: 0000899243-21-027309 · doc4.xml · nonDerivative · entry 2 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,133,035 Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 21:59 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 62,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-027309 · doc4.xml · nonDerivative · entry 1 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,164,023 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 20:09 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 20,000 | $37.71 | $754,254.00 |
DisclosureSEC source: 0000899243-21-025728 · doc4.xml · nonDerivative · entry 1 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,101,523 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted November 17, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.36 to $38.34, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 25, 2021 Filed May 26, 2021 21:27 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 16,700 | $33.22 | $554,720.56 |
DisclosureSEC source: 0000899243-21-020761 · doc4.xml · nonDerivative · entry 2 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,121,523 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.46, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 24, 2021 Filed May 26, 2021 21:27 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 3,300 | $33.01 | $108,917.49 |
DisclosureSEC source: 0000899243-21-020761 · doc4.xml · nonDerivative · entry 1 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,138,223 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.015, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| April 26, 2021 Filed Apr 28, 2021 20:34 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 14,654 | $40.01 | $586,291.89 |
DisclosureSEC source: 0000899243-21-017179 · doc4.xml · nonDerivative · entry 1 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 222,418 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.10, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: Shares held by The Arisa Slutsky Spousal Trust. Read SEC document |
| April 23, 2021 Filed Apr 26, 2021 20:20 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 10,346 | $40.02 | $414,002.43 |
DisclosureSEC source: 0000899243-21-016978 · doc4.xml · nonDerivative · entry 3 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 237,072 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.06, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F5 · ownership.nature: Shares held by The Arisa Slutsky Spousal Trust. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 20:20 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 100 | $39.53 | $3,953.00 |
DisclosureSEC source: 0000899243-21-016978 · doc4.xml · nonDerivative · entry 2 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,141,523 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 20:20 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 19,900 | $39.08 | $777,777.57 |
DisclosureSEC source: 0000899243-21-016978 · doc4.xml · nonDerivative · entry 1 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,141,623 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.52 to $39.51, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · balance_after: This Form 4 corrects the total number of shares directly held by the Reporting Person. On April 5, 2021, the Reporting Person filed a Form 4 which reported that, following all transactions reported, the Reporting Person directly held 3,706,359 shares of Class A common stock and such Form 4 should have showed that the Reporting Person held 3,161,523 shares of Class A common stock. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:02 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Units · Derivative | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014855 · doc4.xml · derivative · entry 3 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 875,000 Underlying: Class A Common Stock · 62,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: On October 30, 2020, the reporting person was granted 1,000,000 restricted stock units, vesting in 16 equal quarterly installments commencing on October 1, 2020, subject to the reporting person's continued employment through each applicable vesting date. F2 · derivative.expiration_date: On October 30, 2020, the reporting person was granted 1,000,000 restricted stock units, vesting in 16 equal quarterly installments commencing on October 1, 2020, subject to the reporting person's continued employment through each applicable vesting date. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:02 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 30,987 | $39.02 | $1,209,112.74 |
DisclosureSEC source: 0000899243-21-014855 · doc4.xml · nonDerivative · entry 2 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,706,359 Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:02 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 62,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-014855 · doc4.xml · nonDerivative · entry 1 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,737,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 21:30 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 16,606 | $37.48 | $622,341.40 |
DisclosureSEC source: 0000899243-21-013310 · doc4.xml · nonDerivative · entry 3 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,130,010 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.34 to $37.85, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 21:30 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 32,694 | $37.01 | $1,209,864.36 |
DisclosureSEC source: 0000899243-21-013310 · doc4.xml · nonDerivative · entry 2 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,146,616 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.34 to $37.33, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 21:30 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 700 | $35.81 | $25,067.98 |
DisclosureSEC source: 0000899243-21-013310 · doc4.xml · nonDerivative · entry 1 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,179,310 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.17 to $36.13, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 21:55 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Units · Derivative | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-000403 · doc4.xml · derivative · entry 3 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 937,500 Underlying: Class A Common Stock · 62,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: On October 30, 2020, the reporting person was granted 1,000,000 restricted stock units, vesting in 16 equal quarterly installments commencing on October 1, 2020, subject to the reporting person's continued employment through each applicable vesting date. F2 · derivative.expiration_date: On October 30, 2020, the reporting person was granted 1,000,000 restricted stock units, vesting in 16 equal quarterly installments commencing on October 1, 2020, subject to the reporting person's continued employment through each applicable vesting date. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 21:55 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 27,482 | $40.34 | $1,108,623.88 |
DisclosureSEC source: 0000899243-21-000403 · doc4.xml · nonDerivative · entry 2 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,674,846 Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 21:55 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 62,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-000403 · doc4.xml · nonDerivative · entry 1 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,702,328 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.